Ocular Manifestations in Patients of HIV(Human Immunodeficiency Virus) Infection on Combined Anti-Retroviral Therapy (CART)

Reference

• World Health Organisation. HIV/AIDS: data and statistics. [Internet]. Available from: https://www.who.int/hiv/data/en/HIV/AIDS:Data-and-statistics-2018. 2018. Accessed November 2018.
   Google Scholar
• National AIDS Control Organization, MoHFW, GoI. Annual report NACO 2017-18. [Internet]. Available from: http://naco.gov.in/documents/annual-reports. 2018. Accessed July 2017.
   Google Scholar
• Hodge WG, Seiff SR, Margolis TP. Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Ophthalmology. 1998;105(5):895–900. doi:10.1016/S0161-6420(98)95033-3.
   PubMed Web of Science ®Google Scholar
• Venkatesh KK, Biswas J, Kumarasamy N. Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus/acquired immune deficiency syndrome. Indian J Ophthalmol. 2008;56(5):391–393. doi:10.4103/0301-4738.42415.
   PubMed Web of Science ®Google Scholar
• Accorinti M, Pirraglia MP, Corradi R, Corsi C, Fabiani C, Pivetti-Pezzi P. Changing Patterns of Ocular Manifestations in HIV Seropositive Patients Treated with HAART. Eur J Ophthalmol. 2006;16:728–732. doi:10.1177/112067210601600511.
   PubMed Web of Science ®Google Scholar
• Gharai S, Venkatesh P, Garg S, Sharma SK, Vohra R. Ophthalmic manifestations of HIV infections in India in the Era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India. Ophthalmic Epidemiol. 2008;15(4):264–271. doi:10.1080/09286580802077716.
   PubMed Web of Science ®Google Scholar
• Ganekal S, Jhanji V, Dorairaj S, Nagarajappa A. Evaluation of ocular manifestations and blindness in HIV/AIDS patients in a tertiary care hospital in South India. OculImmunolInflamm. 2012;20:336–341.
   Google Scholar
• Agarwal A, Singh R, Sharma A, Gupta V, Dogra MR. Ocular manifestations in patients with human immunodeficiency virus infection in the Pre-HAART versus the HAART era in the North Indian population. OculImmunolInflamm. Jun 2017;25(3):396–404.
   Google Scholar
• Biswas J, Sudharshan S. Anterior segment manifestations of human immunodeficiency virus/acquired immune deficiency syndrome. Indian J Ophthalmol. 2008 Sep;56(5):363–365. doi:10.4103/0301-4738.42412.
   PubMed Web of Science ®Google Scholar
• National AIDS Control Organization: National technical guidelines on anti-retroviral treatment. October 2018, New Delhi, NACO: Govt. of India.
   Google Scholar
• World Health Organization. Consolidated ARV guidelines chapter 7: clinical guidance across the continuum of care: antiretroviral therapy; 2013 June 7. [Internet] Available from: http://www.who.int/hiv/pub/guidelines/arv2013/art.
   Google Scholar
• World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children [Internet]. Available from: http://www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf. August 7, 2006. Accessed April 2018 26.
   Google Scholar
• Chalmers RL, Begley CG, Caffery B. Validation of the 5-item dry eye questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Cont Lens Anterior Eye. 2010;33:55–60. doi:10.1016/j.clae.2009.12.010.
   PubMed Web of Science ®Google Scholar
• Murube J, Nemeth J, Hoh H, et al. The triple classification of dry eye for practical clinical use. Eur J Ophthalmol. Nov-Dec. 2005;15(6):660–667. doi:10.1177/112067210501500602.
   PubMed Web of Science ®Google Scholar
• Sahu DK, Namperumalsamy P, Walimbe P, Rajalakshmi. Ocular manifestations of HIV infection/AIDS in South Indian patients. Indian J Ophthalmol. April 1 1999;47(2):79–85.
   Google Scholar
• Acharya PK, Venugopal KC, Karimsab DP, Balasubramanya S. Ocular manifestations in patients with HIV Infection/AIDS who were referred from the ART Centre, Hassan, Karnataka, India. J Clin Diagn Res. 2012 December;6(10):1756–1760. doi:10.7860/JCDR/2012/4738.2637.
   PubMedGoogle Scholar
• Sudharshan S, Kaleemunnisha S, Banu AA, et al. Ocular lesions in 1,000 consecutive HIV-positive patients in India: a long-term study. J Ophthalmic Inflamm Infect. January 3 2013;3(1):2. doi:10.1186/1869-5760-3-2.
   PubMedGoogle Scholar
• Shah SU, Kerkar SP, Pazare AR. Evaluation of ocular manifestations and blindness in HIV/AIDS patients on HAART in a tertiary care hospital in western India. Br J Ophthalmol. 2009 January;93(1):88–90. doi:10.1136/bjo.2008.149237.
   PubMed Web of Science ®Google Scholar
• Pathai S, Deshpande A, Gilbert C, Lawn SD. Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: A cross-sectional study. BMC Infect Dis. 2009 September 23;9:158. doi:10.1186/1471-2334-9-158.
   PubMed Web of Science ®Google Scholar
• Luo J, Jing D, Kozak I, et al. Prevalence of ocular manifestations of HIV/AIDS in the highly active antiretroviral therapy (HAART) era: a different spectrum in Central South China. Ophthalmic Epidemiol. June 2013;20(3):170–175. doi:10.3109/09286586.2013.789530.
   PubMed Web of Science ®Google Scholar
• Tsen CL, Chen YS, Wu KS, et al. Ocular manifestations of human immunodeficiency virus infection at a tertiary referral center in Taiwan. Ocul Immunol Inflamm. 2019;27(7):1071–1076. doi:10.1080/09273948.2018.1499939.
   PubMed Web of Science ®Google Scholar
• Singalavanija T, Ausayakhun S, Tangmonkongvoragul C. Anterior segment and external ocular disorders associated with HIV infections in the era of HAART in Chiang Mai University Hospital, a prospective descriptive cross sectional study. PloS One. 2018 February 21;13(2):e0193161. doi:10.1371/journal.pone.0193161.
   PubMed Web of Science ®Google Scholar
• Amsalu A, Desta K, Nigussie D, Delelegne D. Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern Ethiopia. Int J Ophthalmol. 2017;10(5):776–781. doi:10.18240/ijo.2017.05.20.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Park SJ, Yu HG, et al. Ocular Manifestations of Acquired Immunodeficiency Syndrome in Korea. J Korean Med Sci. 2012;27(5):542. doi:10.3346/jkms.2012.27.5.542.
   PubMed Web of Science ®Google Scholar
• Bekele S, Gelaw Y, Tessema F. Ocular manifestation of HIV/AIDS and correlation with CD4+ cells count among adult HIV/AIDS patients in Jimma town, Ethiopia: a cross sectional study. BMC Ophthalmol. 2013 May;27(13):20. doi:10.1186/1471-2415-13-20.
   Google Scholar
• Yared A, Asfawessen G, Azanaw M. Ocular manifestations of HIV/AIDS patients in Gondar University Hospital, North West Ethiopia. Ethiop J Health Dev. 2006;20:166–169.
   Google Scholar
• Peters RPH, Kestelyn PG, Zierhut M, Kempen JH. The changing global epidemic of HIV and ocular disease. Ocul Immunol Inflamm. 2020;28(7):1007–1014. doi:10.1080/09273948.2020.1751214.
   PubMed Web of Science ®Google Scholar
• Karavellas MP, Plummer DJ, Macdonald JC, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis. 1999;179(3):697–700. doi:10.1086/314639.
   PubMed Web of Science ®Google Scholar
• Geier SA, Libera S, Klauss V, Goebel FD. Sicca syndrome in patients infected with the human immunodeficiency virus. Ophthalmology. 1995 September;102(9):1319–1324. doi:10.1016/S0161-6420(95)30868-8.
   PubMed Web of Science ®Google Scholar
• Agrawal R, Balne PK, Veerappan A, et al. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection. Cytokine. 2016;88:77–84. doi:10.1016/j.cyto.2016.08.026.
   PubMed Web of Science ®Google Scholar